Eversept Partners LP Makes New Investment in Encompass Health Corporation $EHC

Eversept Partners LP acquired a new position in shares of Encompass Health Corporation (NYSE:EHC) in the 4th quarter, HoldingsChannel reports. The firm acquired 106,926 shares of the company’s stock, valued at approximately $11,349,000.

Several other large investors also recently bought and sold shares of EHC. Northwestern Mutual Wealth Management Co. increased its stake in Encompass Health by 3,059,159.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock worth $402,640,000 after buying an additional 3,793,358 shares in the last quarter. Norges Bank purchased a new stake in Encompass Health during the 4th quarter worth approximately $133,221,000. Price T Rowe Associates Inc. MD increased its stake in Encompass Health by 24.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 4,805,413 shares of the company’s stock worth $510,047,000 after buying an additional 948,202 shares in the last quarter. Millennium Management LLC increased its stake in Encompass Health by 140.0% during the 3rd quarter. Millennium Management LLC now owns 1,223,665 shares of the company’s stock worth $155,430,000 after buying an additional 713,738 shares in the last quarter. Finally, 8 Knots Management LLC purchased a new stake in Encompass Health during the 2nd quarter worth approximately $78,644,000. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, EVP Patrick William Tuer sold 682 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the transaction, the executive vice president directly owned 24,755 shares in the company, valued at approximately $2,588,382.80. This represents a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.80% of the company’s stock.

Analysts Set New Price Targets

Several research firms have commented on EHC. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. TD Cowen began coverage on Encompass Health in a report on Thursday, May 28th. They set a “buy” rating and a $125.00 target price on the stock. Barclays lowered their target price on Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a report on Tuesday, May 5th. Leerink Partners set a $152.00 target price on Encompass Health in a report on Friday, May 22nd. Finally, Weiss Ratings restated a “buy (b-)” rating on shares of Encompass Health in a report on Monday, June 8th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $143.86.

Encompass Health Trading Down 1.8%

EHC opened at $98.04 on Thursday. Encompass Health Corporation has a one year low of $92.77 and a one year high of $127.99. The stock has a market capitalization of $9.73 billion, a PE ratio of 16.37, a P/E/G ratio of 2.18 and a beta of 0.72. The business’s 50 day moving average price is $104.26 and its 200 day moving average price is $104.23. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The firm had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.57 billion. During the same period in the prior year, the firm posted $1.37 earnings per share. The firm’s quarterly revenue was up 9.0% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. As a group, equities research analysts expect that Encompass Health Corporation will post 5.97 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a $0.19 dividend. The ex-dividend date is Wednesday, July 1st. This represents a $0.76 dividend on an annualized basis and a yield of 0.8%. Encompass Health’s dividend payout ratio is currently 12.69%.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.